← FDA Drug Approvals (Drugs@FDA)

LIRAGLUTIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2026-03-30

Drug application

FDA Application #

ANDA212552

Application type

Abbreviated New Drug Application (Generic)

Brand name

LIRAGLUTIDE

Generic name

Liraglutide

Active ingredients

LIRAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

FRESENIUS KABI USA

First approval

2026-03-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown